Why does anyone buy Bayer aspirin — or Tylenol, or Advil — when, almost always, there's a bottle of cheaper generic pills, with the same active ingredient, sitting right next to the brand-name pills?
Matthew Gentzkow, an economist at the University of Chicago's Booth school, recently tried to answer this question. Along with a few colleagues, Gentzkow set out to test a hypothesis: Maybe people buy the brand-name pills because they just don't know that the generic version is basically the same thing.
And the Federal Communications Commission has apparently approved a deal giving the Japanese telecom giant SoftBank a controlling stake in SprintNextel, which is the third-largest wireless operator in the U.S. Experts say SoftBank's industry clout should help Sprint become a more robust competitor. NPR's Wendy Kaufman reports.
Some people feel awkward about eating alone in restaurants but a new eatery in Amsterdam has only small tables with single chairs. It requires customers come solo. The restaurant is part culinary endeavor, part social experiment. As its creator says, she wanted to give people "food for thought."